Brief: China Shineway Pharmaceutical Sees Profit Attributable To Increase By 30% To 36% For Year
08/03/2024 10:48
March 8 (Reuters) - China Shineway Pharmaceutical Group
Ltd 2877.HK :
* SEES PROFIT ATTRIBUTABLE TO INCREASE BY 30% TO 36% FOR
YEAR
* SEES INCREASE IN OVERALL SALES REVENUE OF GROUP OF 14% FOR
YEAR
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln